Disseminated superficial actinic porokeratosis. Coexistence with other porokeratotic variants.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 3740871)

Published in Arch Dermatol on August 01, 1986

Authors

J S Dover, T J Phillips, D A Burns, B R Krafchik

Articles by these authors

(truncated to the top 100)

Combined climate and carbon-cycle effects of large-scale deforestation. Proc Natl Acad Sci U S A (2007) 3.94

Lichen sclerosus. Arch Dis Child (1989) 2.76

Leg ulcers. J Am Acad Dermatol (1991) 2.74

Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol (2001) 2.33

Recent advances in wound healing. JAMA (2000) 2.25

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet (2000) 2.24

Pressure ulcers. J Am Acad Dermatol (1998) 2.10

Quantitative trait loci affecting peak bone mineral density in mice. J Bone Miner Res (1998) 2.08

Estimation of genetic correlation: interpretation of experiments using selectively bred and inbred animals. Alcohol Clin Exp Res (1990) 2.03

Bullous pemphigoid following radiotherapy. Clin Exp Dermatol (1995) 2.03

Treatment of tattoos by Q-switched ruby laser. A dose-response study. Arch Dermatol (1990) 2.01

Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci (1998) 1.91

Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell (1997) 1.83

High genetic susceptibility to ethanol withdrawal predicts low ethanol consumption. Mamm Genome (1998) 1.75

Subcutaneous fat necrosis of the newborn: a review of 11 cases. Pediatr Dermatol (2000) 1.70

Nitrogen isotopes as indicators of NO(x) source contributions to atmospheric nitrate deposition across the midwestern and northeastern United States. Environ Sci Technol (2007) 1.68

Neurological complications of systemic sclerosis--a report of three cases and review of the literature. Clin Exp Dermatol (1990) 1.67

Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60

Laser treatment of pigmented lesions--2000: how far have we gone? Arch Dermatol (2000) 1.54

Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol (2001) 1.51

Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med (1993) 1.46

Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol (1990) 1.42

Cutaneous effects and therapeutic uses of heat with emphasis on infrared radiation. J Am Acad Dermatol (1989) 1.41

What syndrome is this? Fetal alcohol syndrome. Pediatr Dermatol (1994) 1.40

Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40

Juvenile spring eruption of the ears: a probable variant of polymorphic light eruption. Br J Dermatol (1991) 1.40

Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg (2001) 1.39

Letter: Disability and coal workers' pneumoconiosis. Br Med J (1974) 1.38

Pseudoporphyria cutanea tarda: two case reports on children receiving peritoneal dialysis and erythropoietin therapy. J Pediatr (1992) 1.38

Identifying genes for alcohol and drug sensitivity: recent progress and future directions. Trends Neurosci (1999) 1.37

Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg (1999) 1.37

Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behav Genet (1997) 1.36

Dried-plasma transport using a novel matrix and collection system for human immunodeficiency virus and hepatitis C virus virologic testing. J Clin Microbiol (2009) 1.32

Precision top-quark mass measurement at CDF. Phys Rev Lett (2012) 1.30

Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav (2005) 1.30

Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice. Neuroscience (2004) 1.27

Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet (1996) 1.24

Establishing the case for CT angiography in the preoperative imaging of abdominal wall perforators. Microsurgery (2008) 1.23

Measurement of the cross section for prompt isolated diphoton production using the full CDF run II data sample. Phys Rev Lett (2013) 1.22

Ventral tegmental area region governs GABA(B) receptor modulation of ethanol-stimulated activity in mice. Neuroscience (2002) 1.21

Genetically correlated effects of selective breeding for high and low methamphetamine consumption. Genes Brain Behav (2009) 1.21

New skin for old: developments in biological skin substitutes. Arch Dermatol (1998) 1.20

Voluntary ethanol drinking in C57BL/6J and DBA/2J mice before and after sensitization to the locomotor stimulant effects of ethanol. Psychopharmacology (Berl) (2001) 1.20

Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J (2000) 1.19

Teaching family medicine in rural clinical clerkships. A WAMI progress report. JAMA (1974) 1.18

Localized scleroderma in childhood: a report of 30 cases. Semin Arthritis Rheum (1994) 1.17

Necrobiosis lipoidica. J Am Acad Dermatol (1991) 1.16

Community clinical clerkships for educating family medicine students. Process of development (a WAMI progress report). J Fam Pract (1975) 1.15

Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes. Br J Dermatol (1987) 1.14

Emphysema in coalworkers. Br Med J (1970) 1.14

Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake. Genes Brain Behav (2011) 1.13

Measurement of the WW + WZ production cross section using the lepton + jets final state at CDF II. Phys Rev Lett (2010) 1.12

Genetic determinants of sensitivity to ethanol in inbred mice. Behav Neurosci (1994) 1.12

The role of lasers and light sources in the treatment of leg veins. Dermatol Surg (1999) 1.11

The diagnostic value of café-au-lait macules. J Am Acad Dermatol (1999) 1.11

First observation of the decay Bs0-->Ds-Ds+ and measurement of its branching ratio. Phys Rev Lett (2008) 1.11

Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology (Berl) (1991) 1.11

Prevalence of skin disease in a cohort of shelter-based homeless men. J Am Acad Dermatol (1999) 1.10

Chronic localized herpes zoster in the acquired immunodeficiency syndrome. Arch Dermatol (1990) 1.10

Tuberous sclerosis complex in children. Am J Dis Child (1981) 1.09

Evidence for a particle produced in association with weak bosons and decaying to a bottom-antibottom quark pair in higgs boson searches at the tevatron. Phys Rev Lett (2012) 1.08

Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07

Confirmation and fine mapping of chromosomal regions influencing peak bone mass in mice. J Bone Miner Res (2001) 1.07

Precise measurement of the W-boson mass with the CDF II detector. Phys Rev Lett (2012) 1.06

QTL analysis and genomewide mutagenesis in mice: complementary genetic approaches to the dissection of complex traits. Behav Genet (2001) 1.06

Direct measurement of the W production charge asymmetry in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2009) 1.04

The tools of preventive medicine in family practice. The annual physical examination? Postgrad Med (1972) 1.03

Search for long-lived massive charged particles in 1.96 TeV pp collisions. Phys Rev Lett (2009) 1.03

Measurement of d sigma/dM and forward-backward charge asymmetry for high-mass Drell-Yan e(+)e(-) pairs from pp macro collisions at square root of s = 1.8 TeV. Phys Rev Lett (2001) 1.02

Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen (2002) 1.02

Duration of sensitization to the locomotor stimulant effects of ethanol in mice. Psychopharmacology (Berl) (1998) 1.01

Hyperplastic pseudofolliculitis barbae associated with cyclosporin. Br J Dermatol (1997) 1.00

Observation of Bs(0)-Bs(0) oscillations. Phys Rev Lett (2006) 1.00

Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99

Progress in a replicated selection for elevated blood ethanol concentrations in HDID mice. Genes Brain Behav (2013) 0.99

Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg (1997) 0.99

Critical role for glucocorticoid receptors in stress- and ethanol-induced locomotor sensitization. J Pharmacol Exp Ther (1995) 0.98

Accessibility and reliability of cutaneous laser surgery information on the World Wide Web. J Am Acad Dermatol (2000) 0.98

Search for large extra dimensions in final states containing one photon or jet and large missing transverse energy produced in pp collisions at square root[s]=1.96 TeV. Phys Rev Lett (2008) 0.97

Quantitative trait loci (QTL) applications to substances of abuse: physical dependence studies with nitrous oxide and ethanol in BXD mice. Behav Genet (1993) 0.96

Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96

Sensitivity to ethanol-induced motor incoordination in 5-HT(1B) receptor null mutant mice is task-dependent: implications for behavioral assessment of genetically altered mice. Behav Neurosci (2000) 0.96

The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation. Genes Brain Behav (2008) 0.96

Bidirectional selective breeding for ethanol effects on locomotor activity: characterization of FAST and SLOW mice through selection generation 35. Alcohol Clin Exp Res (1995) 0.96

Wound healing and aging. Dermatol Clin (1993) 0.96

Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95

Rewarding effect of the neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice. Pharmacol Biochem Behav (1997) 0.95

Darier's disease with hypopigmented macules. Br J Dermatol (1998) 0.95

Measurement of the strong coupling constant from inclusive jet production at the Tevatron pp collider. Phys Rev Lett (2002) 0.94

Group A meningococcal disease in skid rows: epidemiology and implications for control. Am J Public Health (1984) 0.94

Mapping genes that regulate density of dopamine transporters and correlated behaviors in recombinant inbred mice. J Pharmacol Exp Ther (2001) 0.94

Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice. Genes Brain Behav (2008) 0.94

Search for gluinos and scalar quarks in pp collisions at square root[s] = 1.8 TeV using the missing energy plus multijets signature. Phys Rev Lett (2002) 0.93

Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine. Genes Brain Behav (2010) 0.93

Guidelines of care for the use of topical glucocorticosteroids. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.93

Genetic analyses of the biphasic nature of the alcohol dose-response curve. Alcohol Clin Exp Res (1991) 0.93

The cutaneous course of deep inferior epigastric perforators: implications for flap thinning. J Plast Reconstr Aesthet Surg (2008) 0.93

Antinuclear antibodies in children with localized scleroderma. J Rheumatol (1995) 0.92

Search for a fermiophobic Higgs boson decaying into diphotons in pp[over] collisions at sqrt[s] = 1.96 TeV. Phys Rev Lett (2009) 0.92

Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr (2000) 0.92